Clinical Trials Browser

Phase 2 × Interventional × Keratosis, Seborrheic × Clear all

NCT01214564 2011-01-25

Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis

Phase 2 Completed

Keratosis, Seborrheic, Keratosis, Actinic